Teva to Discuss MS and Huntington’s Therapies at Premier Neurology Conference
Teva Pharmaceutical Industries will discuss two of its multiple sclerosis therapies, one that reduces relapses and one that appears…
Articles by Patricia Inacio, PhD
Sanofi Genzyme to Discuss Three Multiple Sclerosis Therapies at Boston Event
Sanofi Genzyme will discuss three of its multiple sclerosis therapies at the American Academy of Neurology annual meeting in Boston, April…
Ampyra Aided Walking in PPMS and RMS Patients Over Long Term, Neurologist Says in Interview
Ampyra (dalfampridine) shows long-term efficacy in improving walking ability in people with multiple sclerosis, according to a study evaluating the treatment’s…
Transcript of Interview on Ampyra Research, MS Walking Ability and Long-Term Use
Multiple Sclerosis News Today interviewed Dr. Linard Filli,
 an MS researcher at the University Hospital Zurich involved in clinical studies of prolonged…
Exposure to Antibiotics Early in Life May Increase Risk for MS and Other Inflammatory Diseases, Study Suggests
The use of antibiotics in childhood, which alters the microbiome — or natural bacteria flora in the gut — may increase…
UMD Team Reverses Paralysis in MS Mouse Model Using Novel Immunotherapy Strategy
Scientists at the University of Maryland have developed an experimental treatment to control the immune system and recover movement in…
Scientists Accelerate Stem Cells’ Production of Brain Cells to Just Days, Study Reports
British scientists have accelerated from weeks to days the process by which stem cells generate brain cells, which could open…
MicroRNA Therapy Restored Myelin Production, Limb Function in MS Mouse Model
Using a small RNA molecule belonging to the family of microRNAs (miRs), scientists could restore myelin in nerve cells and…
EBI2 Receptor Facilitates T-cell Invasion of Brain in MS, Animal Study Shows
Scientists have identified a receptor that promotes the influx of damaging immune T-cells into the brain of a mouse model…
#ACTRIMS2017 – Smoking Significantly Worsens Quality of Life for MS Patients, Study Shows
Multiple sclerosis (MS) patients who smoke have a significantly worse quality of life than non-smoking MS patients, concludes a new study.
#ACTRIMS2017 – Study Reports Possible Link Between Viral Infections, Vitamin D, and Risk for MS
In a U.S. nationwide case study, a team of researchers found evidence for a potential link between viral infections during childhood, vitamin D…
#ACTRIMS2017 – 60-year Follow-up Study of MS Patients Looked at Risks, Causes of Death
A 60-year follow-up study of nearly 1,400 Norwegian patients with multiple sclerosis (MS) analyzed their survival and risk of dying…
#ACTRIMS2017 – Ocrevus Significantly Decreases Disease Activity in MS Patients, Study Shows
Ocrevus (ocrelizumab), an investigational monoclonal antibody, significantly decreases disease activity in patients with multiple sclerosis (MS), and is associated with…
#ACTRIMS2017 – There is Increased Evidence Linking Viruses to MS Risk
Multiple sclerosis (MS) is thought to be caused by genetic factors, but environmental cues are increasingly recognized to have an…
#ACTRIMS2017 – High Salt Diet Seen as Potential Risk Factor for MS in New Study
New evidence strengthens the link between a diet high in salt and multiple sclerosis (MS) development, researchers show. The study, “Sodium…
#ACTRIMS2017 – Lemtrada Maintains Durable Positive Effects in MS Without Additional Treatment
Two Phase 3 clinical trials investigating the long-term effects of Lemtrada (alemtuzumab) in multiple sclerosis (MS) patients showed the drug…
#ACTRIMS2017 – Early MS Evidence Found in Asymptomatic First-degree Relatives of Patients
First-degree relatives of multiple sclerosis (MS) patients may develop asymptomatic disease, suggesting the need to further evaluate family members to develop…
Component of Traditional Medicinal Herb Improves Symptoms in MS Mouse Model, Study Shows
Paeoniflorin (PF), a herb component used in Chinese medicine, improved symptoms and reduced inflammation in a mouse model that recapitulates…
Natural Variations in Interleukin-16 Gene Linked to MS Risk in Small Study
Small natural variations within the DNA sequence of the gene for interleukin-16 (IL-16) were linked to an increased susceptibility to multiple sclerosis (MS)…
Researchers Identify Gene Regions with High Levels of Proteins Linked to MS
A genome-wide study has identified DNA regions associated with higher levels of circulating cytokines, small proteins that pay a role in…
Generic Form of Copaxone, GTR, Safe and Effective, Study Confirms
An extension trial assessing generic glatiramer acetate (GTR) treatment in multiple sclerosis (MS) patients found that the formulation is as…
B-cells Differ in Pediatric- and Adult-onset MS, Study Shows
The immune system B-cells responsible for producing antibodies are different in those who develop multiple sclerosis (MS) as children, than in those who…
Cyclophosphamide May Delay Disability in Secondary Progressive MS, but Tolerability Is an Issue, Study Shows
Cyclophosphamide (CPM) may delay the progression of disability in the first years of secondary progressive multiple sclerosis (SPMS), but patients must…
MS Antibodies Recognize Protein of Common Respiratory Tract Bacteria, Study Finds
Researchers have found a microbial protein from the Haemophilus influenza pathogen that is recognized by antibodies in a subpopulation of…
3-D Structure of CCR2 Receptor, While Bound to Its Inhibitors, Captured for 1st Time
Scientists unraveled the 3-D structure of a key receptor linked to inflammation in multiple sclerosis (MS) — the CC chemokine…
Lower Oxygen in Brain’s Gray Matter Linked to More Impairment in Mouse Study
The less oxygen that a mouse with multiple sclerosis (MS) has in the gray matter of its brain, the more mental and…
Lemtrada Lessens MS Disability in People Who Respond Poorly to Other Therapies, Study Says
Data from the CARE-MS II clinical trial showed that Lemtrada (alemtuzumab) can lessen pre-existing disabilities in patients with relapsing-remitting multiple sclerosis (RRMS)…
Sexual Dysfunction in MS Linked to Depression and Fatigue, Study Shows
In a cross-sectional study, researchers found that sexual dysfunction in patients with multiple sclerosis (MS) is linked to fatigue and depression.
Glial Cells Found to Play a Role in Pain Sensation in MS, Other Disorders
Researchers have discovered that glial cells can also participate in pain sensation and enhance it in several disorders, including multiple…
Lemtrada Targets Circulating Innate Immune Cells in RRMS Patients
Lemtrada (alemtuzumab), a humanized monoclonal antibody, is able to remodel the immune responses of innate immune cells in patients…